NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Candida in petri dish
Durham-based Mycovia Pharmaceuticals has extended its Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women.
The Raleigh-based company, launched in 2016, uses patented thermal food processing technology to produce shelf-stable products that don’t need refrigeration until their packages are opened.
Colorado potato beetle
GreenLight Biosciences, headquartered in Boston, expects to double the size of its Research Triangle Park plant and data science operation over the next two years.
Lung illustration on protective vest
Raleigh-based biotechnology company Arrevus has received an Orphan Drug Designation from the FDA for its ARV-1801, an oral antibiotic to treat cystic fibrosis lung infections, .
Rendering of new Audentes factory in Sanford
Audentes Therapeutics, a San Francisco gene therapy company, today announced plans for a $109.4 million, 209-employee gene therapy production facility in Sanford, a short distance from a $600 million Pfizer gene therapy campus under construction.
Robert Jordan III
Bob Jordan, a visionary leader who helped build the foundation for North Carolina’s global life science leadership, died today at the age of 87. 
Cover of Window on the Workplace 2020
The newly published 2020 edition of the “Window on the Workplace” study analysis says North Carolina's long-term commitment to biopharma workforce readiness will need to adjust and grow to meet coming demand.
Venture Connect 2020 logo
Early registration for next month’s Venture Connect Summit at the Raleigh Convention Center closes on Feb. 14, offering discounted admission to the entrepreneurial showcase and networking event.
Duke scientist puts slides into scanner
Duke scientists say an instrumentation grant from NCBiotech enables them to use cutting-edge digital imaging and AI technologies to advance cancer research, diagnostics and to support a vast new initiative called AI Health.
T3D logo
T3D Therapeutics has enlisted an all-star team of Alzheimer’s disease experts to guide the science behind its potential drugs for treating the affliction.
Shutterstock image of elderly couple
T3D Therapeutics is launching a Phase 2 clinical trial with its unique product candidate, T3D-959, to treat mild to moderate forms of Alzheimer’s disease.
Carrot field
Learn how large ag tech companies decide what to pursue when they’re looking 15 years into the future at the next Ag Tech Professional Forum Feb. 19 at the North Carolina Biotechnology Center.
Bioscience ventures in southeastern NC can compete for up to $20,000 in awards this spring through a new program created by NCBiotech and supported by UNCW and the New Hanover Regional Medical Center.
Lung images
A successful Phase 3 trial of Polarean Imaging’s drug-device combination for lung imaging has the Research Triangle Park company poised to seek next-step advice from FDA regulators.
The North Carolina Biotechnology Center awarded 23 grants and loans totaling $2.1 million during the past fiscal quarter to bioscience companies, universities and non-profit organizations.